Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
出版年份 2014 全文链接
标题
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 28, Issue 5, Pages 677-685
出版商
Springer Nature
发表日期
2014-11-28
DOI
10.1038/modpathol.2014.146
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Splicing factor mutations and cancer
- (2014) Kenichi Yoshida et al. Wiley Interdisciplinary Reviews-RNA
- Test-Firing Ammunition for Spliceosome Inhibition in Cancer
- (2013) S. M. Dehm CLINICAL CANCER RESEARCH
- A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
- (2013) D. S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Hairy-Cell Leukemia Presenting As Lytic Bone Lesions
- (2013) Madison Tanner Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
- (2013) J William Harbour et al. NATURE GENETICS
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The spliceosome as a target of novel antitumour drugs
- (2012) Sophie Bonnal et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic Lymphocytic Leukemia withSF3B1Mutation
- (2012) Victor Quesada et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
- (2011) Liying Fan et al. ACS Chemical Biology
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- Biological validation that SF3b is a target of the antitumor macrolide pladienolide
- (2011) Akira Yokoi et al. FEBS Journal
- Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer
- (2011) Daniela Hungermann et al. JOURNAL OF PATHOLOGY
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- GOBO: Gene Expression-Based Outcome for Breast Cancer Online
- (2011) Markus Ringnér et al. PLoS One
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor Activity
- (2009) Chandraiah Lagisetti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells
- (2009) B. J. Albert et al. MOLECULAR CANCER THERAPEUTICS
- The emerging role of splicing factors in cancer
- (2008) Ana Rita Grosso et al. EMBO REPORTS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search